Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Guardant Health
MedTech
FDA approves Guardant’s colorectal cancer screening blood test
While it won't replace a colonoscopy, the Shield test is designed to funnel adults ages 45 and up at an average risk for the disease toward the exam.
Conor Hale
Jul 29, 2024 11:00am
FDA panel gives OK to Guardant's colorectal cancer blood test
May 23, 2024 5:15pm
Guardant preps for FDA review of colorectal cancer blood test
May 13, 2024 1:48pm
Exact, Guardant tout next-gen colorectal cancer screening tests
Mar 14, 2024 1:27pm
Guardant hit with $83M verdict in TwinStrand patent lawsuit
Nov 15, 2023 11:41am
Guardant, Illumina bury legal hatchet, ink cancer partnership
Aug 9, 2023 10:20am
